Hypoxia-induced endothelial dysfunction in apolipoprotein E-deficient mice; effects of infliximab and L-glutathione

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 400-410

  Tuleta, Izabela ^a   Franҫa, Carolina Nunes ^a   Wenzel, Daniela ^a   Fleischmann, Bernd ^a   Nickenig, Georg ^a   Werner, Nikos ^a   Skowasch, Dirk ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Atherosclerosis; Endothelium; Free radicals; Hypoxia; Progenitor cells

Indexed keywords

APOLIPOPROTEIN E; GELATINASE B; GLUTATHIONE; INFLIXIMAB; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE MARROW; CHRONIC INTERMITTENT HYPOXIA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RISK FACTOR; SLEEP DISORDERED BREATHING; VASCULAR RING; ANIMAL; ANOXIA; AORTIC DISEASES; BLOOD; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DRUG SCREENING; KNOCKOUT MOUSE; MEMBRANE MICROPARTICLE; PATHOPHYSIOLOGY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; SPLEEN; VASCULAR ENDOTHELIUM;

ANIMALS; ANOXIA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIOXIDANTS; AORTIC DISEASES; APOLIPOPROTEINS E; BONE MARROW; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GLUTATHIONE; INFLIXIMAB; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; REACTIVE OXYGEN SPECIES; SLEEP APNEA, OBSTRUCTIVE; SPLEEN;

EID: 84907086974     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.08.021     Document Type: Article

References (39)

1. Peker Y., Hedner J., Norum J., Kraiczi H., Carlson J. Increased incidence of cardiovascular disease in middle-age men with obstructive sleep apnea: a 7-year follow up. Am J Respir Crit Care Med 2002, 166:159-165.
2. Tuleta I., Pabst S., Juergens U.R., Nickenig G., Skowasch D. Obstructive sleep apnoea as a risk factor for atherosclerosis - implication for preventive and personalised treatment. EPMA J 2011, 2:39-47.
3. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea. JAMA 2003, 290:1906-1914.
4. Yun C.H., Jung K.H., Chu K., Kim S.H., Ji K.H., Park H.K., et al. Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol 2010, 6:89-98.
5. Ayers L., Ferry B., Craig S., Nicoll D., Stradling J.R., Kohler M. Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur Respir J 2009, 33:574-580.
6. Akinnusi M.E., El Solh A.A. Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea?. Am J Respir Crit Care Med 2009, 179:328-329.
7. Kizawa T., Nakamura Y., Takahashi S., Sakurai S., Yamauchi K., Inoue H. Pathogenic role of angiotensin II and oxidized LDL in obstructive sleep apnoea. Eur Respir J 2009, 34:1390-1398.
8. Jelic S., Lederer D.J., Adams T., Padeletti M., Colombo P.C., Factor P., et al. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag 2009, 5:909-920.
9. Jun J., Reinke C., Bedja D., Berkowitz D., Bevans-Fonti S., Li J., et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2010, 209:381-386.
10. Arnaud C., Poulain L., Le´vy P., Dematteis M. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice. Atherosclerosis 2011, 219:425-431.
11. Xiao Q., Zeng L., Zhang Z., Margariti A., Ali Z.A., Channon K.M., et al. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol 2006, 26:2244-2251.
12. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
13. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93:980-989.
14. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93:e17-e24.
15. Schro¨der K., Kohnen A., Aicher A., Liehn E.A., Bu¨chse T., Stein S., et al. NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ Res 2009, 105:537-544.
16. Urao N., Ushio-Fukai M. Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med 2013, 54:26-39.
17. Belaidi E., Joyeux-Faure M., Ribuot C., Launois S.H., Levy P., Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009, 53:1309-1317.
18. Grebe M., Eisele H.J., Weissmann N., Schaefer C., Tillmanns H., Seeger W., et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006, 173:897-901.
19. Kerekes G., Solte´sz P., De´r H., Veres K., Szabo´ Z., Ve´gva´ri A., et al. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis. Ann N Y Acad Sci 2009, 1173:814-821.
20. Lomaestro B.M., Malone M. Glutathione in health and disease: pharmacotherapeutic issues. Ann Pharmacother 1995, 29:1263-1273.
21. Allahdadi K.J., Walker B.R., Kanagy N.L. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705-709.
22. Fletcher E.C., Orolinova N., Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002, 92:627-633.
23. Dematteis M., Godin-Ribuot D., Arnaud C., Ribuot C., Stanke-Labesque F., Pe´pin J.L., et al. Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. ILAR J 2009, 50:262-281.
24. Zimmer S., Steinmetz M., Asdonk T., Motz I., Coch C., Hartmann E., et al. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ Res 2011, 108:1358-1366.
25. + apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006, 26:112-116.
26. Kebschull M., Haupt M., Jepsen S., Deschner J., Nickenig G., Werner N. Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. PLoS One 2013, 8. e54860.
27. Dematteis M., Julien C., Guillermet C., Sturm N., Lantuejoul S., Mallaret M., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008, 177:227-235.
28. Jun J., Polotsky V.Y. Metabolic consequences of sleep-disordered breathing. ILAR J 2009, 50:289-306.
29. Ip M.S., Tse H.F., Lam B., Tsang K.W., Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
30. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. Am J Med 2000, 109:315-323.
31. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
32. Westerweel P.E., Teraa M., Rafii S., Jaspers J.E., White I.A., Hooper A.T., et al. Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One 2013, 8. e60357.
33. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9:1370-1376.
34. Teraa M., Sprengers R.W., Westerweel P.E., Gremmels H., Goumans M.J., Teerlink T., et al. JUVENTAS study group bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PLoS One 2013, 8. e55592.
35. Ling L., Shen Y., Wang K., Jiang C., Fang C., Ferro A., et al. Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One 2012, 7. e50739.
36. He S., He Z., Chen Y., Ye J., Zong D., Zhang Y., et al. C-Kit/c-Kit ligand interaction of bone marrow endothelial progenitor cells is influenced in a cigarette smoke extract-induced emphysema model. Exp Lung Res 2013, 39:258-267.
37. Tepper O.M., Carr J., Allen R.J., Chang C.C., Lin C.D., Tanaka R., et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010, 59:1974-1983.
38. Kaczmarek E., Bakker J.P., Clarke D.N., Csizmadia E., Kocher O., Veves A., et al. Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One 2013, 8. e70559.
39. Jiang S., Jin F., Li D., Zhang X., Yang Y., Yang D., et al. Intermittent hypobaric hypoxia promotes atherosclerotic plaque instability in ApoE-deficient mice. High Alt Med Biol 2013, 14:175-180.